Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Flanagan W. Michael (CIK 1841990) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-22). Recent activity: Sell RNA (22,812 shares), Sell RNAM (150,365 shares), Sell RNA (3,976 shares), Sell RNA (2,558 shares), Sell RNA (2,373 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Atrium Therapeutics, Inc. (RNA) | Director | Sell | 22,812 | $204,167 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Chief Scientific Officer | Sell | 150,365 | $0 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 3,976 | $288,061 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 2,558 | $185,327 |
| 2026-01-09 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 2,373 | $171,402 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Buy | 27,500 | $0 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 13,695 | $984,260 |
| 2025-09-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Buy | 20,000 | $284,400 |
| 2025-09-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 20,000 | $778,800 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Buy | 20,000 | $284,400 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | Sell | 20,000 | $657,600 |
Source: SEC Form 4 filings · as of 2026-09-22